FOLD Q4 2020 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$71M+27.6% YoY

Gross Profit

$61M86.7% margin

Operating Income

-$65M-91.9% margin

Net Income

-$71M-101.2% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+4.6%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$51M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$887M

Total Liabilities

$600M

Stockholders' Equity

$286M

Cash & Equivalents

$163M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$71M	$55M	+27.6%
Gross Profit	$61M	$48M	+26.5%
Operating Income	-$65M	-$89M	+27.2%
Net Income	-$71M	-$90M	+20.4%

Geographic Segments

Non-US

$49M70%

UNITED STATES

$21M30%